Surfactant in respiratory distress syndrome and lung injury

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 129, Issue 1, 2001, Pages 287-294

  Hallman, Mikko ^a   Glumoff, Virpi ^a   Rämet, Mika ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adult respiratory distress syndrome; Amniotic fluid; Cytokines; Lung surfactant; Premature infant; Respiratory distress syndrome; Surfactant proteins

Indexed keywords

INTERLEUKIN 1; LUNG SURFACTANT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR;

ATELECTASIS; CELL MATURATION; CONFERENCE PAPER; DISEASE PREDISPOSITION; HUMAN; LUNG INJURY; NEWBORN DISEASE; NONHUMAN; PROTEIN SECRETION; RACE DIFFERENCE; REGENERATION; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ANIMALIA;

EID: 0034996563     PISSN: 10956433     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-6433(01)00324-5     Document Type: Conference Paper

References (68)

1. Anzueto A., Jubran A., Ohar J.A., et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. J. Am. Med. Assoc. 278:1997;1426-1431.
2. Avery M.E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Childhood. 97:1959;517-523.
3. Batenburg J.J., Hallman M. Develapmental biochemistry of alveoli. Scarpelli E.M. Pulmonary Physiology: Fetus-Newborn-Child-Adolescent, 2nd ed. 1990;106-139 Lea & Febiger, Philadelphia.
4. Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of the innate immunity. Curr. Opin. Microbiol. 3:2000;23-28.
5. Bry K., Lappalainen U., Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J. Clin. Invest. 99:1997;2992-2999.
6. Bullard K.M., Sonne J., Hawgood S., Harrison M.R., Adzick N.S. Tracheal ligation increases cell proliferation but decreases surfactant protein in fetal murine lungs in vitro. J. Pediatr. Surg. 32:1997;207-211.
7. Clements J.A. Dependence of pressure-volume characteristics of lungs on intrinsic surface active material. Am. J. Physiol. 16:1956;592.
8. Clements J.A., Avery M.E. Lung surfactant and neonatal respiratory distress syndrome. Am. J. Resp. Crit. Care Med. 157:1998;S59-S66.
9. Clements J.A., Tooley W.H. Kinetics of surface-active material in fetal lung. Hodson C.W.A. Development of the Lung. 1972;349-366 Marcel Dekker, New York.
10. Cockshutt A.M., Possmayer F. Metabolism of surfactant lipids and proteins in the developing lung. Robertson B., Van Golde L.M.G., Batenburg J.J. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. 1992;339-377 Elsevier Science, Amsterdam.
11. Crouch E.C. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 19:1998;177-201.
12. Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am. J. Obstet. Gynecol. 173:1995;322-335.
13. Eggleton P., Reid K.B.M. Lung surfactant proteins involved in innate immunity. Curr. Opin. Immunol. 11:1999;28-33.
14. Eijking E.P., van Daal G.J., Tenbrinck R., et al. Effect of surfactant replacement on pneumocystic carinii pneumonia in rats. Intensive Care Med. 17:1991;475-478.
15. Emerson G.A., Bry K., Hallman M., Jobe A.H., Wada N., Ikegami M. Intra-amniotic interleukin-1 alpha treatment alters postnatal adaptation in premature lambs. Biol. Neonate. 72:1997;370-379.
16. Enhörning G., Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics. 50:1972;55-66.
17. Floros J., Hoover R.R. Genetics of the hydrophilic surfactant proteins A and D. Biochim. Biophys. Acta. 1408:1998;312-322.
18. Floros J., Veletza S.V., Kotikalapudi P., et al. Dinucleotide repeats in the human surfactant protein B gene and respiratory distress syndrome. J. Biochem. 305:1995;583-590.
19. Galdes-Sebaldt M., Sheller J.R., Grogaard J., Stahlman M. Prematurity is associated with abnormal airway function in childhood. Pediatr. Pulmonol. 7:1989;725-729.
20. Garred P., Pressler T., Madsen H.O., et al. Association of mannose-binding lectin gene heterozygosity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104:1999;431-437.
21. Gluck L., Motoyama E.K., Smits H.L., Kulovich M.V. The biochemical development of surface activity in mammalian lung. I. The surface active phospholipids; the separation and distribution of surface-active lecithin in the lung of the developing rabbit fetus. Pediatr. Res. 1:1967;237-246.
22. Gluck L., Kulovich M.V., Borer R.C. Jr., Brenner P.H., Anderson G.G., Spellacy W.N. Diagnosis of the respiratory distress syndrome by amniocentesis. Am. J. Obstet. Gynecol. 109:1971;440-445.
23. Glumoff V., Väyrynen O., Kangas T., Hallman M. Degree of lung maturity determines the direction of the interleukin-1-induced effect on the expression of surfactant proteins. Am. J. Respir. Cell Mol. Biol. 22:2000;280-288.
24. Greene K.E., Wright J.R., Steinberg K.P., et al. Serial changes in surfactant-associated proteins in lung and serum before and after the onset of ARDS. Am. J. Resp. Crit. Care Med. 160:1999;1843-1850.
25. Gregory T.J., Longmore W.J., Moxley M.A., et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1991;1976-1981.
26. Gregory T.J., Steinberg K.P., Spragg R., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. of Resp. Crit. Care Med. 155:1997;1309-1315.
27. Haataja R., Rämet M., Marttila R., Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum. Mol. Gen. 9:2000;2751-2760.
28. Halliday H.L. Synthetic or natural surfactants. Acta Paediatr. 86:1997;233-237.
29. Halliday, H.L., Ehrenkranz, R.A., 2000. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford update software.
30. Hallman M. Antenatal diagnosis of lung maturity. Robertson B., Van Golde L.M.G., Batenburg J.J. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. 1992;425-458 Elsevier Science, Amsterdam.
31. Hallman M. Cytokine, pulmonary surfactant and consequences of intrauterine infection. Biol. Neonate. 76:(Suppl. 1):1999;2-9.
32. Hallman M., Spragg R., Harrell J.H., Moser K.M., Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:1982;673-683.
33. Hallman M., Merritt T.A., Akino T., Bry K. Surfactant protein A, phosphatidylcholine and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of RDS and outcome of small premature infants. Am. Rev. Respir. Dis. 144:1991;1376-1384.
34. Hallman M., Bry K., Hoppu K., Lappi M., Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. New Engl. J. Med. 326:1992;1233-1239.
35. Hallman M., Merritt T.A., Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin. Pharmacokinet. 26:1994;215-232.
36. Harju, K., Glumoff, V., Hallman, M., 2001. Ontogeny of Toll-like receptors TLR2 and TLR4 in mouse. Pediatr. Res., in press.
37. Hartog A., Vasquez de Anda G.F., Gommers D., et al. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation. Br. J. Anaesth. 82:1999;81-86.
38. Hawgood S., Derrick M., Poulain F. Structure and properties of surfactant protein B. Biochim. Biophys. Acta. 1408:1998;150-160.
39. Hoover R.R., Floros J. SP-A 3′-UTR is involved in glucocorticoid inhibition of human SP-A gene expression. Am. J. Physiol. 276:1999;L917-L924.
40. Ikegami M., Korfhagen T.R., Whitsett J.A., et al. Characteristics of surfactant from SP-A-deficient mice. Am. J. Physiol. 275:1998;L247-L254.
41. Jobe A.H. Surfactant function and metabolism. Boynton B.B., Carlo W.A., Jobe A.H. New Therapies for Neonatal Respiratory Disease. 1994;16-35 Cambridge Univ Press, New York.
42. Jobe A.H., Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annu. Rev. Physiol. 62:2000;825-846.
43. Jobe A.H., Newham J.P., Willet K.E., et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am. J. Obstet. Gynecol. 182:2000;401-408.
44. Kala P., Have T.T., Nielsen H., Dunn M., Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr. Res. 43:1998;169-177.
45. King R.J., Coalson J.J., deLemos R.A., Gerstmann D.R., Seidner S.R. Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. Am. J. Resp. Crit. Care Med. 151:1995;1989-1997.
46. Klein J.M., Nielsen H.C. Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development. J. Clin. Invest. 91:1993;425-431.
47. Korfhagen T.R., LeVine A.M., Whitsett J.A. Surfactant protein A (SP-A) gene targeted mice. Biochim. Biophys. Acta. 1408:1998;296-302.
48. Lankenau H.M. A genetic and statistical study of the respiratory distress syndrome. Eur. J. Pediatr. 123:1976;167-177.
49. Merritt T.A., Soll R.F., Hallman M. Overview of exogenous surfactant replacement therapy. J. Intensive Care Med. 8:1993;205-228.
50. Mydrianthopoulos N.C., Churchill J.A., Baszynski A.J. Respiratory distress syndrome in twins. Acta Genet. Med. Gemellol. 20:1971;199-204.
51. Nogee L.M., Garnier G., Dietz H.C., et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J. Clin. Invest. 93:1994;1860-1863.
52. Northway W.H. Jr., Rosan R.C., Porter D.Y. Pulmonary disease following respiratory therapy. New Engl. J. Med. 276:1967;357-374.
53. Paananen R., Glumoff V., Hallman M. Surfactant protein A and D expression in the porcine Eustachian tube. FEBS Lett. 452:1999;141-144.
54. Paananen, R., Glumoff, V., Sormunen, R., Voorhout, W., Hallman, M., 2000. Expression and localization of lung surfactant protein B in Eustachian tube epithelium. Am. J. Physiol. Lung, in press.
55. Pandit P.B., Dunn M.S., Colucci E.A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 95:1995;32-36.
56. Pattle R.E. Properties, function and origin of the alveolar lining layer. Nat. (Lond.). 175:1955;1125-1126.
57. Pattle R.E., Kratzing C.C., Parkinson C.E., et al. Maturity of fetal lungs tested by production of stable microbubbles in amniotic fluid. Br. J. Obstet. Gynaecol. 86:1979;615-622.
58. Pelkonen A.S., Hakulinen A.L., Turpeinen M., Hallman M. Effect of neonatal surfactant therapy on lung function at school age in children born very preterm. Pediatr. Pulmonol. 25:1998;182-190.
59. Rämet M., Haataja R., Marttila R., Floros J., Hallman M. Association between the surfactant protein A gene locus and respiratory distress syndrome in the Finnish population. Am. J. Hum. Genet. 66:2000;1569-1579.
60. Rämet, M., Löfgren, J., Alho, O.-P., Hallman, M., 2000b. Surfactant protein-A gene locus associated with recurrent otitis media. J. Pediatr., in press.
61. Soll, R.F., Dargaville, P., 2000. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database of Systematic Reviews 2:CD002054.
62. Väyrynen O., Glumoff V., Kangas T., Hallman M. Endotoxin-induced changes in expression of surfactant proteins are dependent on the degree of lung maturity. Pediatr. Res. 45:1999;896.
63. Watterberg K.L., Demers L.M., Scott S.M., Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 97:1996;210-215.
64. Wilcox D.T., Irish M.S., Holm B.A., Glick P.L. Pulmonary parenchymal abnormalities in congenital diaphragmatic hernia. Clin. Perinatol. 23:1996;771-779.
65. Wiswell T.E., Smith R.M., Katz L.B., et al. Bronchopulmonary segmental lavage with Surfaxin (KL4-surfactant) for acute respiratory distress syndrome. Am. J. Resp. Crit. Care Med. 160:1999;1188-1195.
66. Wright J.R., Zlogar D.F., Taylor J.C., Zlogar T.M., Restrepo C.I. Effects of endotoxin on surfactant protein A and D stimulation of NO production by alveolar macrophages. Am. J. Physiol. 276:1999;L650-L658.
67. Yost C.C., Soll R.F. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. The Cochrane Library, Issue 1. 2000;Update Software, Oxford.
68. Zimmerman J.J., Farrell P.M. Advances and issues in bronchopulmonary dysplasia. Curr. Probl. Pediatr. 24:1994;159-170.